WMS Partners’s Compugen CGEN Stock Holding History

WMS Partners’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-23,000	Closed	-$43K	–	266
2022 Q2	$43K	Hold	23,000	–	–	0.01%	249
2022 Q1	$74K	Buy	+23,000	New	+$77.7K	0.01%	255

Other funds holding CGEN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

WMS Partners's CGEN Position: Q3 2022 in Review

WMS Partners sold out of Compugen (CGEN) in Q3 2022, closing a stake of 23,000 shares — an estimated $43K sold.

WMS Partners first reported a position in CGEN in Q1 2022 and held it in 2 quarters. The position peaked at $74K in Q1 2022. 81 funds tracked by Wall St. Rank hold CGEN as of Q3 2022.

WMS Partners reported no remaining Compugen position as of Q3 2022 after selling out during the quarter.
WMS Partners sold 23,000 Compugen shares in Q3 2022, an estimated $43K.
WMS Partners first reported a position in Compugen in Q1 2022 and held it in 2 quarters.
WMS Partners's Compugen position peaked at $74K in Q1 2022.
81 funds tracked by Wall St. Rank held Compugen as of Q3 2022.

Based on WMS Partners's 13F filing for Q3 2022, filed 8 Nov 2022.